Medicine
Tudriqev 1000000 PFU/mL injectable suspension
Tudriqev 1000000 PFU/mL injectable suspension is a prescription medicine containing Vusolimogene oderparepvec for intratumor use, marketed by Replimune, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
If a freezer is not available, refer to Table 4 for refrigeration guidelines…
Key facts
- Active ingredient (INN)
- Vusolimogene oderparepvec
- Brand
- Tudriqev
- Strength
- 1000000 PFU/mL
- Dosage form
- Injectable suspension
- Route
- Intratumor
- Packs
- 1 vial
- Marketing authorisation holder
- Replimune
- Manufacturer
- Replimune
- Origin register
- US FDA, United States
- Storage
- If a freezer is not available, refer to Table 4 for refrigeration guidelines. Table 4: Storage of Thawed TUDRIQEV in Vial and Syringe Storage Condition Thawed Vial Prepared Syringe Refrigeration: 2°C to 8°C (36°F to 46°F) 10 6 PFU/mL vial up to 2 days 10 7 PFU/mL vial up to 4 days Use within 2 hours of preparation Room temperature: 15°C to 25°C… Store TUDRIQEV at -70°C to -90°C (-94°F to -130°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 September 2026
- Identifiers
- RxCUI 2751862, 2751869, 2751872 +1DailyMed set ID 26627b8d-91ac-4f76-a213-7e25efd024d1NDC 83616-106Application BLA125827
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 83616-106-11 | Replimune | 4 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Vusolimogene oderparepvec
Clinical summary
Vusolimogene oderparepvec is a prescription medicine indicated in combination with nivolumab for the treatment of adult patients with unresectable advanced cutaneous melanoma who experienced disease progression with a programmed death receptor-1 (PD-1)-blocking antibody-based regimen. MedsAcross supplies Vusolimogene oderparepvec for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Vusolimogene oderparepvecFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tudriqev prescribing information (Replimune) · U.S. National Library of Medicine, DailyMed
Need Tudriqev 1000000 PFU/mL injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.